Hamilton, Thorlabs to develop, market confocal imaging system
Hamilton Thorne (HT) and Thorlabs have signed an original equipment manufacturing (OEM) supply agreement, which provides HT with OEM and distribution rights for a new confocal imaging system currently under development at the Newton, N.J.-based Thorlabs.
The agreement grants HT the exclusive rights to sell the confocal product to the regenerative medical research market that the Beverly, Mass.-based HT serves worldwide.
“The cost of current confocal imaging systems is prohibitive to many labs and discussions with leading scientists revealed a true need for a more cost-effective solution,” said Meg Spencer, CEO and co-founder of HT.
Currently, confocal imaging requires the purchase of a complete microscope system. HT said that the confocal imaging system being developed by this partnership will allow confocal imaging capability on standard inverted microscopes, according to both companies.
The agreement grants HT the exclusive rights to sell the confocal product to the regenerative medical research market that the Beverly, Mass.-based HT serves worldwide.
“The cost of current confocal imaging systems is prohibitive to many labs and discussions with leading scientists revealed a true need for a more cost-effective solution,” said Meg Spencer, CEO and co-founder of HT.
Currently, confocal imaging requires the purchase of a complete microscope system. HT said that the confocal imaging system being developed by this partnership will allow confocal imaging capability on standard inverted microscopes, according to both companies.